Trial Profile
Open-label, single-center, randomized and parallel-group study to compare the effect of hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP) and that of fluticasone propionate dry powder inhaler (FP-DPI) on large and small airways involvement in bronchial asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Beclometasone (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 22 Dec 2009 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 17 Jul 2009 Actual initiation date (Mar 2007) added as reported by University Hospital Medical Information Network - Japan record.
- 17 Jul 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.